查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1291485

乳腺癌液体活检市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Breast Cancer Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

市场概述：

全球乳腺癌液体活检市场规模在2022年达到1.107亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到3.262亿美元，在2023-2028年期间呈现17.81%的增长率（CAGR）。

乳腺癌液体活检是指一种非侵入性的医疗程序，利用血液作为样本来识别肿瘤标志物。它有助于评估乳腺癌疾病的进展，检测表皮生长因子受体（EGFR）的基因突变，帮助临床医生在正确的时间选择最佳行动方案。这一过程中使用的一些常见生物标志物包括循环肿瘤细胞（CTC）、细胞外囊泡、循环肿瘤DNA等。乳腺癌液体活检有几个好处，包括最小的侵入性、新病变的特征、癌症治疗的药物和治疗目标的识别等等。

乳腺癌液体活检的市场趋势：

乳腺癌发病率的增长以及对非侵入性医疗程序的需求升级是推动全球乳腺癌液体活检市场的主要原因。除此之外，消费者对与液体活检技术相关的众多好处的认识不断提高，包括更快的结果、更低的成本、最小的健康风险、非侵入性等，也促进了市场增长。此外，各种全球组织正在开展宣传活动，对个人进行乳房健康和癌症诊断措施的教育。再加上政府和私人对乳腺癌活检和其他相关医疗程序的报销政策越来越多，这为市场创造了一个积极的前景。除此之外，许多制造商正在对引进先进的活检技术进行大量投资，以加强乳腺癌管理的几个方面，如预测预后、早期诊断复发、连续取样、有效纵向监测疾病进展和对治疗的反应等。此外，个性化治疗的新兴趋势加上聚合酶链反应（PCR）和下一代测序（NGS）在癌症检测中的广泛采用，将在未来几年继续推动全球乳腺癌液体活检市场。

本报告中回答的关键问题：

  • 2022年全球乳腺癌液体活检市场的规模是多少？
  • 2023-2028年期间，全球乳腺癌液体活检市场的预期增长率是多少？
  • COVID-19对全球乳腺癌液体活检市场的影响是什么？
  • 推动全球乳腺癌液体活检市场的关键因素是什么？
  • 基于产品服务的全球乳腺癌液体活检市场的细分情况是怎样的？
  • 全球乳腺癌液体活检市场的主要地区有哪些？
  • 谁是全球乳腺癌液体活检市场的主要参与者/公司？

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球乳腺癌液体活检市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按产品服务分類的市场

  • 试剂盒
    • 市场趋势
    • 市场预测
  • 仪器
    • 市场趋势
    • 市场预测
  • 服务业
    • 市场趋势
    • 市场预测

第7章 ：循环生物标志物的市场细分

  • 循环肿瘤细胞(CTCs)
    • 市场趋势
    • 市场预测
  • 无细胞DNA (cfDNA)
    • 市场趋势
    • 市场预测
  • 细胞外囊泡（EVs）
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第8章：按终端用户分類的市场

  • 参考实验室
    • 市场趋势
    • 市场预测
  • 医院和医生实验室
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十章：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十一章 ：价值链分析

第十二章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章 ：价格分析

第十四章：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • Biocept Inc.
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fluxion Biosciences Inc.
    • Guardant Health Inc.
    • Illumina Inc.
    • Menarini Silicon Biosystems (The Menarini Group)
    • NeoGenomics Laboratories Inc.
    • Qiagen
    • Sysmex Europe SE (Sysmex Corporation)
Product Code: SR112023A6047

Market Overview:

The global breast cancer liquid biopsy market size reached US$ 110.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 326.2 Million by 2028, exhibiting a growth rate (CAGR) of 17.81% during 2023-2028.

Breast cancer liquid biopsy refers to a non-invasive medical procedure that utilizes blood as a sample for the identification of tumor markers. It assists in evaluating the progression of breast cancer disease and detects Epidermal Growth Factor Receptor (EGFR) gene mutations that help clinicians in choosing the best course of action at the right time. Some of the common biomarkers that are used in this process include circulating tumor cells (CTC), extracellular vesicles, circulating tumor DNA, etc. Breast cancer liquid biopsy offers several benefits, including minimal invasiveness, characterization of new lesions, drug and therapeutic target identifications for cancer treatment, etc.

Breast Cancer Liquid Biopsy Market Trends:

The growing prevalence of breast cancer along with the escalating demand for non-invasive medical procedures is primarily driving the global breast cancer liquid biopsy market. In addition to this, the rising consumer awareness towards numerous benefits associated with the liquid biopsy technique, including quicker results, lower cost, minimal health risk, non-invasiveness, etc., is also augmenting the market growth. Moreover, various global organizations are conducting awareness campaigns to educate individuals about breast health and cancer diagnostic measures. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer biopsy and other related medical procedures, is creating a positive outlook for the market. Apart from this, numerous manufacturers are making significant investments in the introduction of advanced biopsy techniques that enables the enhancement of several aspects of breast cancer management, such as prediction of prognosis, early diagnosis of relapse, serial sampling, efficient longitudinal monitoring of disease progress and response to treatment, etc. Furthermore, the emerging trend of personalized therapeutics coupled with the widespread adoption of polymerase chain reaction (PCR) and next-generation sequencing (NGS) for cancer detection will continue to drive the global breast cancer liquid biopsy market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global breast cancer liquid biopsy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product services, circulating biomarker and end user.

Breakup by Product Services:

  • Reagent Kits
  • Instruments
  • Services

Breakup by Circulating Biomarker:

  • Circulating Tumor Cells (CTCs)
  • Cell-Free DNA (cfDNA)
  • Extracellular Vesicles (EVs)
  • Others

Breakup by End User:

  • Reference Laboratories
  • Hospitals and Physician Laboratories
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biocept Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Menarini Silicon Biosystems (The Menarini Group), NeoGenomics Laboratories Inc., Qiagen and Sysmex Europe SE (Sysmex Corporation).

Key Questions Answered in This Report:

  • What was the size of the global breast cancer liquid biopsy market in 2022?
  • What is the expected growth rate of the global breast cancer liquid biopsy market during 2023-2028?
  • What has been the impact of COVID-19 on the global breast cancer liquid biopsy market?
  • What are the key factors driving the global breast cancer liquid biopsy market?
  • What is the breakup of the global breast cancer liquid biopsy market based on the product services?
  • What are the key regions in the global breast cancer liquid biopsy market?
  • Who are the key players/companies in the global breast cancer liquid biopsy market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Breast Cancer Liquid Biopsy Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Product Services

  • 6.1  Reagent Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Circulating Biomarker

  • 7.1  Circulating Tumor Cells (CTCs)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Cell-Free DNA (cfDNA)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Extracellular Vesicles (EVs)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Reference Laboratories 
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Hospitals and Physician Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10   SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Biocept Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2  Bio-Rad Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3  F. Hoffmann-La Roche AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4  Fluxion Biosciences Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  Guardant Health Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6  Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7  Menarini Silicon Biosystems (The Menarini Group)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8  NeoGenomics Laboratories Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Qiagen
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10  Sysmex Europe SE (Sysmex Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Breast Cancer Liquid Biopsy Market: Major Drivers and Challenges
  • Figure 2: Global: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Breast Cancer Liquid Biopsy Market: Breakup by Product Services (in %), 2022
  • Figure 5: Global: Breast Cancer Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2022
  • Figure 6: Global: Breast Cancer Liquid Biopsy Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Breast Cancer Liquid Biopsy Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Breast Cancer Liquid Biopsy (Reagent Kits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Breast Cancer Liquid Biopsy (Reagent Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Breast Cancer Liquid Biopsy (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Breast Cancer Liquid Biopsy (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Breast Cancer Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Breast Cancer Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Breast Cancer Liquid Biopsy (Circulating Tumor Cells (CTCs)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Breast Cancer Liquid Biopsy (Circulating Tumor Cells (CTCs)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Breast Cancer Liquid Biopsy (Cell-Free DNA (cfDNA)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Breast Cancer Liquid Biopsy (Cell-Free DNA (cfDNA)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Breast Cancer Liquid Biopsy (Extracellular Vesicles (EVs)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Breast Cancer Liquid Biopsy (Extracellular Vesicles (EVs)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Breast Cancer Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Breast Cancer Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Breast Cancer Liquid Biopsy (Reference Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Breast Cancer Liquid Biopsy (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Breast Cancer Liquid Biopsy (Hospitals and Physician Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Breast Cancer Liquid Biopsy (Hospitals and Physician Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Breast Cancer Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Breast Cancer Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Breast Cancer Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Breast Cancer Liquid Biopsy Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Breast Cancer Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Breast Cancer Liquid Biopsy Industry: SWOT Analysis
  • Figure 78: Global: Breast Cancer Liquid Biopsy Industry: Value Chain Analysis
  • Figure 79: Global: Breast Cancer Liquid Biopsy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Breast Cancer Liquid Biopsy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Product Services (in Million US$), 2023-2028
  • Table 3: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2023-2028
  • Table 4: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Breast Cancer Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Breast Cancer Liquid Biopsy Market: Competitive Structure
  • Table 7: Global: Breast Cancer Liquid Biopsy Market: Key Players